Table 4 Alterations in immunological profile relative to hCG-levels. MIP1a, IL-1ra, TNF alpha, MCP1, IL-6, TPO and TGF-beta1 were assessed in pg/ml, hCG in mIU/ml
| Ratio |
MIP1a (pg/ml)/ hCG (mIE/ml) |
IL-1ra (pg/ml)/ hCG (mIE/ml) |
TNF alpha(pg/ml)/ hCG (mIE/ml) |
MCP1(pg/ml)/ hCG (mIE/ml) |
IL-6 (pg/ml)/ hCG (mIE/ml) |
TPO (pg/ml)/ hCG(mIE/ml) |
TGF-beta1 (pg/ml)/ hCG(mIE/ml) |
|---|---|---|---|---|---|---|---|
| mean ± SEM (ongoing pregnancy) | 0.16 ± 0.04 | 2.22 ± 0.72 | 0.02 ± 0.01 | 0.5 ± 0.16 | 0.007 ± 0.002 | 2.50 ± 0.70 | 68.04 ± 22.37 |
| mean ± SEM (abortion) | 1.02 ± 0.38 | 7.83 ± 2.30 | 0.07 ± 0.02 | 1.44 ± 0.40 | 0.016 ± 0.003 | 5.47 ± 1.31 | 149.35 ± 33.89 |
| Ratio | 0.15 | 0.28 | 0.29 | 0.35 | 0.44 | 0.45 | 0.45 |
| p-value | < 0.05 | < 0.05 | < 0.05 | < 0.05 | < 0.05 | < 0.05 | < 0.05 |